Investigational Drug Information for Treosulfan
✉ Email this page to a colleague
What is the development status for investigational drug Treosulfan?
Treosulfan is an investigational drug.
There have been 46 clinical trials for Treosulfan.
The most recent clinical trial was a Phase 3 trial, which was initiated on October 1st 2009.
The most common disease conditions in clinical trials are Leukemia, Myelodysplastic Syndromes, and Preleukemia. The leading clinical trial sponsors are medac GmbH, Fred Hutchinson Cancer Research Center, and National Cancer Institute (NCI).
Summary for Treosulfan
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 148 |
| WIPO Patent Applications | 102 |
| Japanese Patent Applications | 148 |
| Clinical Trial Progress | Phase 3 (2009-10-01) |
| Vendors | 36 |
Recent Clinical Trials for Treosulfan
| Title | Sponsor | Phase |
|---|---|---|
| Low Dose Treosulfan Based Conditioning Regimen and PTCy in HSCT for Nijmegen Breakage Syndrome | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | Phase 2 |
| PTCy and and Ruxolitinib for GVHD Prophylaxis After HSCT With Thymoglobulin in Conditioning Regimen in Patients With Inborn Errors of Immunity | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | Phase 2 |
| Phase III Study Comparing GVHD Prophylaxis With ATG-thymoglobulin to ATLG-grafalon in Elderly Patients With Acute Myeloid Leukemia or Myelodysplasic Syndrome and Receiving an Allogeneic Hematopoietic Stem Cell Transplantation With a 10/10 HLA Matche | Assistance Publique - Hôpitaux de Paris | Phase 3 |
Clinical Trial Summary for Treosulfan
Top disease conditions for Treosulfan
Top clinical trial sponsors for Treosulfan
US Patents for Treosulfan
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
